Bee Venom Allergy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Bee Venom Allergy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT04259359

Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure

Venom immunotherapy (VIT) is an established treatment for Hymenoptera venom allergy and provides long-term protection from further generalized reactions in almo…

Austria, Germany, Spain266 participantsStarted 2019-05-02

Treatment: Insect Venom

All recent trials (5 shown)

CompletedNot Applicable

NCT04435678

Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer…

About 20% of the general population are affected by an allergy - with an upward trend. Quite often, allergic people do not consider their disease as serious and…

Austria839 participantsStarted 2020-07-22

Treatment: ALEX² test using the MAX 45k automated laboratory system

UnknownNot Applicable

NCT02968394

Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions

The purpose of this study is to evaluate if omalizumab co-treatment may allow reintroduction of honey bee venom immunotherapy in patients with immunotherapy tre…

Slovenia11 participantsStarted 2014-03

Treatment: omalizumab

Bee Venom Allergy

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure

All recent trials (5 shown)

Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer…

Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure

All recent trials (5 shown)

Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer…

Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions

Efficacy and Safety of a Purified Standardised Bee Venom Preparation

Maintenance Bee-Venom Immunotherapy Administered at 6-Month Intervals Does Not Protect Against re-Stings